The committee, formed by InMode's board, evaluated multiple proposals for a potential transaction with help from outside financial and legal advisers. After reviewing the final bids, it concluded that ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on InMode, with a price target of $21.00. According to TipRanks, Miksic is a 4-star analyst with an average return of 4.6% ...

InMode ended the year with a strong cash position of $555.3 million and returned $127.4 million to shareholders through share repurchases during 2025. Looking ahead, the company plans to launch two ...

YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Tuesday reported net income of $27 million in its fourth quarter. The Yokneam, Israel-based company said it had net income of 42 ...

InMode said Q4 came in “slightly better than expected” but full-year revenue fell about 6% to $370.5M, and management expects 2026 to be a stabilization year rather than a return to growth despite ...

InMode ( (INMD)) has issued an announcement. On February 2, 2026, InMode issued a statement responding to market speculation surrounding a publicly announced non-binding proposal from Steel Partners ...

The MarketWatch News Department was not involved in the creation of this content. YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...

Jan 28 (Reuters) - Investment firm Steel Partners said on Wednesday it had offered $18 per share to acquire a 51% stake in InMode (INMD.O), opens new tab, ‌sending the Israel-based medical technology ...